Why the study?
Does higher peak cardiac troponin level predict MACE in patients with acute myocardial infarction?
Population
345 consecutive patients with acute myocardial infarction, including Type 1, Type 2, STEMI, and NSTEMI
Comparison
Higher quartiles of peak cardiac troponin level vs Lower quartiles of peak cardiac troponin level
Design
Cohort
Follow-up
mean 30.6 months
Authors
Loading...
May refine subtype-specific prognostication in Type 1/STEMI AMI; leaves open utility and validation in Type 2/NSTEMI.
Does higher peak cardiac troponin level predict MACE in patients with acute myocardial infarction?
Peak cardiac troponin levels predict long-term MACE and mortality in patients with Type 1 AMI and STEMI, but not in those with Type 2 AMI or NSTEMI.
González et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: